ClinicalTrials.gg
CompletedNCT04112680CMTUpdated Jan 22, 2020

Contagious Misinformation Trial

An interventional study of Debunking Misinformation through Audio Dramas and Control group audio jingles in Misinformation, sponsored by Karolinska Institutet. Completed at 1 site in Sierra Leone. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-01-22.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
750
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In the Contagious Misinformation Trial the investigators aim to debunk prevalent misinformation about an infectious disease using two evidence-based methods of debunking. The two debunking methods are packaged in two audio dramas of 4 episodes each, which will be sent to the WhatsApp of participants who are randomised to intervention group 1 or 2. The control group will receive audio messages about a different topic. The primary outcome is the reduction in belief in two misinformation statements about the infectious diseases.

02

Conditions studied

  • Misinformation

Keywords

  • Misinformation
  • Communication
  • Infectious diseases
03

In context

Communication

719 studies on the registry are indexed under Communication; 159 are open to participants now.

This study's enrollment of 750 is above the median of 144 across 571 interventional studies indexed under Communication.

Browse Communication studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,148 studies on the registry; 276 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults
  • Living in Freetown
  • In possession of a mobile phone that has WhatsApp
  • Fluent in Krio

Exclusion criteria

Exclusion Criteria:

  • Deafness
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
750 participants (actual)

Study arms

  • Experimental
    Intervention group 1

    Audio messages in this group are focussed on providing a Plausible Alternative to the misinformation

    Behavioral: Debunking Misinformation through Audio Dramas

  • Experimental
    Intervention group 2

    Audio messages in this group focus on Avoiding the Misinformation and instead only provide the correct information

    Behavioral: Debunking Misinformation through Audio Dramas

  • Placebo comparator
    Control group

    Audio messages in this control group are on a different topic

    Behavioral: Control group audio jingles

Interventions

  • BehavioralDebunking Misinformation through Audio Dramas

    The audio dramas (one drama of 4 episodes per intervention group), aim to debunk misinformation about an infectious disease. The content of the two dramas differ in the two groups; in intervention group 1, the drama will state the misinformation and provide a plausible alternative, delivered through a trusted source, in line with world views. In intervention group 2, the audio drama will avoid mentioning the misinformation and instead only state the correct information about the infectious disease

  • BehavioralControl group audio jingles

    The control group will receive audio jingles about exclusive breastfeeding

06

What researchers measure

Primary outcomes

  1. Change in the belief in misinformation

    The change in the belief in misinformation will be measured through Yes/No questions in the baseline and follow-up surveys. Using logistic regression models, the prevalence of the belief in misinformation about 2 aspects of an infectious disease compared to the control group will be analysed using an intention-to-treat and per-protocol analysis

    Time frame: Up to 2 months

Secondary outcomes

  1. Inadvertent promotion of misinformation: the backfire effect

    To test whether the interventions might inadvertently have promoted the belief in misinformation, the same yes/no questions as the primary outcome will be used in ordinal logistic regression models to analyse if the there has been a backfire effect in the intervention groups, compared to the control group.

    Time frame: Up to 2 months

  2. As treated analysis of primary outcomes

    The Yes/No questions of the primary outcomes will be tested in an as-treated analysis. The investigators will only include participants who can correctly recall the basic storylines of the audio messages.

    Time frame: Up to 2 months

  3. Knowledge about preventive methods

    Using an open question, asking the respondent to name up to 3 preventive methods, a score will be created. For every correct answer, the participants gets a point, and one point is subtracted for every wrong answer; leading to a potential score of -3 to +3. Ordinal logistic regression models will be fitted to compare the scores of the intervention groups with the control group.

    Time frame: Up to 2 months

  4. Health-related discussions among family/friend

    The question asking whether the participant has discussed the content of the audio messages will be used for this analysis, together with the question about how often the participant discussed health issues with family/friends. Logistic regression models will be fitted to test whether the interventions have influenced health-related discussions with family or friends, as compared to the control group.

    Time frame: Up to 2 months

  5. Method of administration

    To understand if the intervention works outside of WhatsApp, 60 additional people will be recruited who do not have WhatsApp. Participants will instead be called and listen to the audio dramas on the phone; 30 will listen to the audio drama of intervention group 1 and 30 will listen to the audio drama of intervention group 2. The two primary outcomes will be analysed similar to the primary outcome analysis (ITT and per protocol) among the 2 groups and compared to the control group, as well as to their equivalent group of respondents with WhatsApp.

    Time frame: Up to 2 months

  6. Differences in self-efficacy

    Participants will answer 3 questions about their perceived self-efficacy on 3 specific preventive behaviours. Answers are on a 5-item scale: from not at all true to exactly true. Ordinal logistic regression models will be specified to test whether the interventions had an influence on people's self-efficacy about three specific preventive behaviours, compared to the control group.

    Time frame: Up to 2 months

  7. Risk perception & preventive methods

    Risk perception about the infectious disease will be measured with a question that asks how likely it is that the participants gets the disease in the next year. A question which asks what kind of actions the participants has undertaken, or is planning to undertake, to prevent infection with the disease - will be used to assess if and what kind of actions are taken. Several analyses will be carried out to test whether the intervention influenced risk perception and preventive methods. Furthermore, analyses will be carried out to determine if the a change in risk perception influenced preventive methods.

    Time frame: Up to 2 months

  8. Objective versus subjective learning

    In the follow-up survey, there is a question asking if the participant feels like he/she learned from the audio messages (yes/no question). A Chi-Square analysis will be done to determine whether those who feel like they learned also learned objectively, using the two primary outcomes.

    Time frame: Up to 2 months

07

Study locations

1 site
  • Focus1000
    Freetown, Western Area, Sierra Leone
08

References and documents

Publications

  • Winters M, Oppenheim B, Sengeh P, Jalloh MB, Webber N, Pratt SA, Leigh B, Molsted-Alvesson H, Zeebari Z, Sundberg CJ, Jalloh MF, Nordenstedt H. Debunking highly prevalent health misinformation using audio dramas delivered by WhatsApp: evidence from a randomised controlled trial in Sierra Leone. BMJ Glob Health. 2021 Nov;6(11):e006954. doi: 10.1136/bmjgh-2021-006954. PubMed 34758970 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — After publication of the primary analysis and study results, the anonymised data will be published in a public repository

Supporting information: Statistical analysis plan, Informed consent form

Time frame: January 2022

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2019 to primary completion in Dec 2019, 2 months.

Of 390 non-industry interventional studies with no phase under Communication, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 36. This study's 2 months is below that.

Counting every sponsor, half of 394 studies reached it within 18 months; a quarter within 6 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 27, 2019
First posted
Oct 2, 2019
StartActual
Oct 7, 2019
Primary completionActual
Dec 21, 2019
CompletionActual
Dec 21, 2019
Last update
Jan 22, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 22, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04112680
Responsible party
Helena Nordenstedt (Principal Investigator, Karolinska Institutet) — Principal investigator
First posted
Oct 2, 2019
Start date
Oct 7, 2019
Primary completion
Dec 21, 2019
Completion
Dec 21, 2019
Last update
Jan 22, 2020

Study contacts

Helena Nordenstedt, MD PHD
principal investigator · Karolinska Institutet

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion